Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Large-scale testing (Phase 3)Not Yet RecruitingNCT06093425What this trial is testingCombination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ AdenocarcinomaWho this might be right forGastric CancerGastroesophageal-junction CancerAdvanced Cancer Transcenta Therapeutics (Hangzhou) Co., Ltd. 820
Not applicableStudy completedNCT02722785What this trial is testingPeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal JunctionWho this might be right forGastro-esophageal Cancer Jesper Frank Christensen, PhD 40
Large-scale testing (Phase 3)Looking for participantsNCT04997837What this trial is testingStudy of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaWho this might be right forGastric Cancer Fudan University 433
Not applicableNot Yet RecruitingNCT07260734What this trial is testingAUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)Who this might be right forOESOPHAGO-GASTRIC CARCINOMAOesophageal AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma+5 more Imperial College London 6,000
Testing effectiveness (Phase 2)Ended earlyNCT00064259What this trial is testingA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more National Cancer Institute (NCI) 15
Early research (Phase 1)Ended earlyNCT02268825What this trial is testingPhase I Study MK-3475 With Chemotherapy in Patients With Advanced GI CancersWho this might be right forAdvanced GI Cancer University of Utah 39
Testing effectiveness (Phase 2)Study completedNCT00084617What this trial is testingPhase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction CarcinomaWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT03013010What this trial is testingPREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyWho this might be right forStomach NeoplasmGastroEsophageal CancerAdenocarcinoma+2 more Shanghai Cancer Hospital, China 204
Early research (Phase 1)Study completedNCT03720678What this trial is testingEvaluate Immunotherapy Combinations in Participants With Gastrointestinal MalignanciesWho this might be right forGastroEsophageal CancerColorectal Cancer Arcus Biosciences, Inc. 44
Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT05311176What this trial is testingIMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)Who this might be right forGastric CancerCancer of StomachGastric Adenocarcinoma+3 more Imugene Limited 7
Large-scale testing (Phase 3)UnknownNCT01523015What this trial is testingEfficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal Junction Medical University of Lublin 100
Early research (Phase 1)UnknownNCT05396326What this trial is testingA Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerWho this might be right forGastric Cancer Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00319735What this trial is testingCetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction CarcinomasWho this might be right forEsophageal Cancer Nasser Hanna, M.D. 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604What this trial is testingInvestigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2Who this might be right forGastric CancerGastroesophageal Junction Cancer AstraZeneca 33
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Testing effectiveness (Phase 2)UnknownNCT06250894What this trial is testingNeoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric JunctionWho this might be right forPD-1Neoadjuvant ChemoradiotherapyGastroesophageal Junction Cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 32
Testing effectiveness (Phase 2)Looking for participantsNCT07749586What this trial is testingEvaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Arvinas Inc. 499
Testing effectiveness (Phase 2)UnknownNCT04781686What this trial is testingApatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric CancerWho this might be right forMetastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma Zhou Fuxiang 35